Skip to main content
NVDA-2.58%AAPL+3.15%GOOGL+0.50%MSFT-0.13%AMZN-0.26%TSM-1.46%SPCX+0.70%AVGO-0.67%META-1.29%TSLA-0.60%SKHY-4.39%MU-4.61%BRK-B-0.24%LLY+0.04%JPM-0.72%WMT-0.10%AMD-3.24%V-0.17%XOM+0.85%ASMLa-1.66%JNJ-0.04%INTC-4.93%MA-0.53%0700.HK-1.94%1398.HK+0.79%ORCL-4.28%ABBV+1.09%BAC-0.57%CSCO-1.08%CVX-0.28%COST-0.14%KO+0.67%LRCX-5.12%CAT-1.58%AP2d-1.55%0005.HK-0.78%AMAT-2.74%UNH-0.99%HSBA.L-1.30%DELL-3.27%PG+0.48%MS-1.16%GE-0.76%3988.HK+0.84%1816.HK+0.23%0857.HK-3.26%NFLX-0.19%HD-1.90%0939.HK+1.66%GS-1.28%NZDJPY-2.64%AUDJPY-1.85%CHFJPY-1.61%NZDCAD-1.47%EURNZD+1.44%NZDUSD-1.43%GBPNZD+1.39%GBPJPY-1.26%EURJPY-1.24%USDJPY-1.24%CADJPY-1.18%NZDCHF-1.07%USDZAR+1.02%USDNOK+0.90%USDSEK+0.90%EURZAR+0.84%AUDNZD+0.81%GBPZAR+0.76%EURNOK+0.72%EURSEK+0.71%AUDCAD-0.70%USDTHB+0.67%AUDDKK-0.65%AUDUSD-0.62%EURAUD+0.62%GBPAUD+0.58%CHFNOK+0.56%CHFSEK+0.56%AUDSGD-0.55%USDMXN+0.53%USDPLN+0.45%NZDSGD-0.43%GBPTRY+0.41%CADCHF+0.41%NOKJPY-0.39%USDCHF+0.39%EURCHF+0.37%GBPCHF+0.34%GBPHKD+0.32%GBPMXN-0.28%USDSGD+0.28%EURPLN+0.26%AUDCHF-0.24%SGDJPY+0.23%NZDMXN-0.20%EURHKD-0.19%USDDKK+0.18%USDILS+0.16%USDTRY+0.11%USDCNH+0.10%EURSGD+0.09%GBPCAD-0.09%AUDNOK+0.07%EURCNH-0.06%EURCAD-0.06%CHFSGD-0.06%PLNJPY+0.06%EURCZK-0.05%USDCOP-0.04%EURGBP+0.04%USDCAD-0.04%GBPUSD-0.03%USDHKD+0.02%EURUSD-0.01%GBPSGD+0.01%EURDKK0.00%XPTUSD-6.16%GAGUSD-5.41%XAGUSD-5.41%UKOIL+5.19%USOIL+5.04%HG1-4.88%XAUUSD-1.85%GAUUSD-1.85%XNGUSD+1.63%SUGAR0.00%S10.00%COFFEE0.00%BTCUSD-1.43%ETHUSD-0.13%USDTUSD-0.02%XRPUSD-3.04%SOLUSD-1.72%TRXUSDT+0.18%ZECUSDT-9.00%DOGEUSD-2.63%XMRUSDT+0.93%LINKUSD-1.35%XLMUSD-1.44%BCHUSDT-9.83%LTCUSD-1.66%UNIUSD-1.56%TONUSD+24.88%HBARUSDT-2.45%SUIUSD-4.15%TAOUSDT-5.36%AAVEUSD-2.39%DOTUSDT-1.74%ICPUSDT-0.94%ONDOUSDT-3.15%WLDUSDT-2.91%ATOMUSDT-2.92%ARBUSDT-0.91%JUPUSDT-3.39%INJUSDT-2.24%STXUSDT-4.53%FETUSDT-2.86%TIAUSDT-0.87%PYTHUSDT-1.42%SEIUSDT-6.02%IMXUSDT-3.85%GRTUSDT-3.45%WIFUSDT-5.38%OPUSDT-3.00%POLUSDT-4.46%IOTAUSDT-3.74%AXSUSDT-2.47%FARTCOINUSDT-2.90%EOSUSDT-2.66%DYDXUSDT-1.99%ORDIUSDT-0.80%GALAUSDT-3.09%NOTUSDT-2.97%RONINUSDT-2.64%NVDA-2.58%AAPL+3.15%GOOGL+0.50%MSFT-0.13%AMZN-0.26%TSM-1.46%SPCX+0.70%AVGO-0.67%META-1.29%TSLA-0.60%SKHY-4.39%MU-4.61%BRK-B-0.24%LLY+0.04%JPM-0.72%WMT-0.10%AMD-3.24%V-0.17%XOM+0.85%ASMLa-1.66%JNJ-0.04%INTC-4.93%MA-0.53%0700.HK-1.94%1398.HK+0.79%ORCL-4.28%ABBV+1.09%BAC-0.57%CSCO-1.08%CVX-0.28%COST-0.14%KO+0.67%LRCX-5.12%CAT-1.58%AP2d-1.55%0005.HK-0.78%AMAT-2.74%UNH-0.99%HSBA.L-1.30%DELL-3.27%PG+0.48%MS-1.16%GE-0.76%3988.HK+0.84%1816.HK+0.23%0857.HK-3.26%NFLX-0.19%HD-1.90%0939.HK+1.66%GS-1.28%NZDJPY-2.64%AUDJPY-1.85%CHFJPY-1.61%NZDCAD-1.47%EURNZD+1.44%NZDUSD-1.43%GBPNZD+1.39%GBPJPY-1.26%EURJPY-1.24%USDJPY-1.24%CADJPY-1.18%NZDCHF-1.07%USDZAR+1.02%USDNOK+0.90%USDSEK+0.90%EURZAR+0.84%AUDNZD+0.81%GBPZAR+0.76%EURNOK+0.72%EURSEK+0.71%AUDCAD-0.70%USDTHB+0.67%AUDDKK-0.65%AUDUSD-0.62%EURAUD+0.62%GBPAUD+0.58%CHFNOK+0.56%CHFSEK+0.56%AUDSGD-0.55%USDMXN+0.53%USDPLN+0.45%NZDSGD-0.43%GBPTRY+0.41%CADCHF+0.41%NOKJPY-0.39%USDCHF+0.39%EURCHF+0.37%GBPCHF+0.34%GBPHKD+0.32%GBPMXN-0.28%USDSGD+0.28%EURPLN+0.26%AUDCHF-0.24%SGDJPY+0.23%NZDMXN-0.20%EURHKD-0.19%USDDKK+0.18%USDILS+0.16%USDTRY+0.11%USDCNH+0.10%EURSGD+0.09%GBPCAD-0.09%AUDNOK+0.07%EURCNH-0.06%EURCAD-0.06%CHFSGD-0.06%PLNJPY+0.06%EURCZK-0.05%USDCOP-0.04%EURGBP+0.04%USDCAD-0.04%GBPUSD-0.03%USDHKD+0.02%EURUSD-0.01%GBPSGD+0.01%EURDKK0.00%XPTUSD-6.16%GAGUSD-5.41%XAGUSD-5.41%UKOIL+5.19%USOIL+5.04%HG1-4.88%XAUUSD-1.85%GAUUSD-1.85%XNGUSD+1.63%SUGAR0.00%S10.00%COFFEE0.00%BTCUSD-1.43%ETHUSD-0.13%USDTUSD-0.02%XRPUSD-3.04%SOLUSD-1.72%TRXUSDT+0.18%ZECUSDT-9.00%DOGEUSD-2.63%XMRUSDT+0.93%LINKUSD-1.35%XLMUSD-1.44%BCHUSDT-9.83%LTCUSD-1.66%UNIUSD-1.56%TONUSD+24.88%HBARUSDT-2.45%SUIUSD-4.15%TAOUSDT-5.36%AAVEUSD-2.39%DOTUSDT-1.74%ICPUSDT-0.94%ONDOUSDT-3.15%WLDUSDT-2.91%ATOMUSDT-2.92%ARBUSDT-0.91%JUPUSDT-3.39%INJUSDT-2.24%STXUSDT-4.53%FETUSDT-2.86%TIAUSDT-0.87%PYTHUSDT-1.42%SEIUSDT-6.02%IMXUSDT-3.85%GRTUSDT-3.45%WIFUSDT-5.38%OPUSDT-3.00%POLUSDT-4.46%IOTAUSDT-3.74%AXSUSDT-2.47%FARTCOINUSDT-2.90%EOSUSDT-2.66%DYDXUSDT-1.99%ORDIUSDT-0.80%GALAUSDT-3.09%NOTUSDT-2.97%RONINUSDT-2.64%
ES

Eurofins Scientific SE (ERFp)

Euronext Paris • Healthcare

€70.92
-€0.01 (-0.0%)
Market closed

September 10, 2026 at 15:30 UTC

Open€70.84
Day Range€70.2 - €71.52
Avg. Volume (3M)250.7K
Market Cap€12.2B
P/E Ratio23.6
52 Week Range
€54.86€74.78

Interactive Chart

19:08:31 UTC

Metrics Over Time

Where the Money Goes

Q2 2026
Revenueeverything earned€3.7B100%
Gross Profitminus cost of goods€499M13%
Operating Incomeminus R&D and overhead€499M13%
Net Incomeminus taxes and the rest€302M8%

In plain terms: out of every €100 in revenue, Eurofins Scientific SE keeps €8 as net profit.

Fundamentals & Financials

Revenue (TTM)
€7.3B
Net Income (TTM)
€530.4M
EPS (TTM)
€3
ROA (TTM)
4.77%
Current Ratio
1.13
Dividend Yield
1.06%

TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.

Earnings

€0.6Q2 2019
€0.32Q4 2019
-23.4%Q2 2020€0.73

% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS

Latest report — Q2 2020
Miss -23.4%

Eurofins Scientific’s first half of fiscal 2026 saw adjusted EPS beat expectations while revenue came in line, with the company reporting the results on July 23, 2026. Adjusted EPS of EUR 2.10 topped the EUR 1.91 estimate (+9.9%), while revenue of EUR 3.701 billion was in line with the EUR 3.705 billion consensus (-0.1%) and rose ~3% year over year (up from about EUR 3.6 billion a year ago). Profitability was reflected in a gross margin of roughly 14% and an operating margin also near 14%, alongside gross profit of about EUR 499.0 million and operating income of around EUR 499.0 million. Net income climbed roughly 23% to about EUR 302.0 million, up from around EUR 246.6 million in the prior-year period. The business generated operating cash flow of roughly EUR 575.0 million and paid about EUR 128.0 million in dividends during the half-year.

View full earnings history

About Eurofins Scientific SE

Eurofins Scientific SE is a healthcare testing and diagnostics company listed on Euronext Paris as ERF.PA. It provides analytical testing and laboratory services, diagnostics, and related compliance support across food, environmental, clinical, and industrial markets, and generated EUR 7.3 billion of revenue in FY2025.

Name
Eurofins Scientific SE
CEO
Gilles G. Martin
Website
www.eurofins.com
Industry
Healthcare
Year Founded
1987
Employees
65,000

Today's Snapshot

AI-generated

ERFp ended the day slightly higher at 71.28, in line with a flat sector. At the close, ERFp was within 4.7% of its 52-week high of 74.78.

Trading Volume

Below 10d avg (282.4K)

254.8K

vs S&P 500 Today

Outperforming Market

+0.95%

Updated: September 10, 2026 at 14:04 UTC

Technical Indicators

3 Buy3 Neutral2 Sell
ERFp shows modest constructive underpinnings with the price roughly 71.18 trading around the VWAP and above several longer-term moving averages, while short-term averages are slightly higher, creating a mixed near-term picture. ADX indicates a moderate but not dominant trend, and momentum measures are neutral, with MACD near flat; ATR is subdued, implying limited intraday variability. On-balance volume is slightly negative, but the VWAP alignment and strength in longer-term averages provide a mild technical lift. Technical takeaway: Buy.
All signals
  • EMA (5 indicators)$66.24 - $71.74
    Buy
  • RSI (14)47.94
    Neutral
  • Stochastic %K (14, 3, 3)41.25
    Neutral
  • MACD Level (12, 26)0.46
    Neutral

Peers & Related Assets

BIMpbioMérieux S.A.
€71.6-0.1%
IPN.PAIpsen S.A.
ABVX.PAAbivax S.A.
BIM.PAbioMérieux S.A.
VIRP.PAVirbac S.A.
LBIRD.PALumibird S.A.
Stay Ahead of the Market

Get premium market insights delivered directly to your inbox.